HOME >> MEDICINE >> NEWS
Antiplatelet drug found to reduce risk of recurrent heart attacks and stroke is cost-effective

ORLANDO -- The antiplatelet medicine clopidogrel is not only effective in reducing the risk of recurrent heart attack and stroke, it is also extremely cost-effective, according to data presented today by researchers from Emory University at the American Heart Association's Scientific Sessions.

"We have three separate investigations showing uniform results in both the short and long-term use of clopidogrel. Specifically, the use of clopidogrel in addition to aspirin produces a significant risk reduction in recurrent heart attack, stroke or cardiovascular death," says William Weintraub, M.D. FACC, Director, Emory Center for Outcomes Research in the Division of Cardiology, Department of Medicine, Emory University School of Medicine, who presented the data. "The study findings and the cost-effectiveness data suggest that at least one year of therapy with clopidogrel is an attractive value. In fact, we believe it should be the standard of care for this patient population."

The Emory University investigators analyzed the drug's cost-effectiveness ratio in two major clinical studies -- the CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) trial and the CREDO (Clopidogrel for the Reduction of Events During Observation) trial -- as well as a substudy of CURE, called PCI-CURE . Cost-effectiveness ratio is the incremental cost of using an intervention to obtain a unit of effectiveness (such as dollars per life-year gained) compared to another treatment or no treatment.

Based on CURE, the Emory researchers found that the cost-effectiveness ratio was $6,173 per life year gained. PCI-CURE, which evaluated people who received clopidogrel for up to one year after having an angioplasty or stent, demonstrated a cost-effectiveness ratio of $5,910 per life year gained. In CREDO, patients were given a dose of clopidogrel before having an angioplasty or stenting procedures and continued on clopidogrel therapy for up to one year. The cost-effect
'"/>

Contact: Sherry Baker
emoryheartnews@aol.com
404-377-1398
Emory University Health Sciences Center
12-Nov-2003


Page: 1 2

Related medicine news :

1. Antiplatelet drugs: comparison of clopidogrel with aspirin
2. Acupuncture found to lower elevations in blood pressure
3. Proteins found in urine of pregnant women could help diagnose preeclampsia
4. Potential drug target for treating cocaine abuse found
5. Similar results found in both older and younger patients undergoing weight-loss surgery
6. Infectious agent linked to mad cow disease found in organs other than the brain
7. Generation gap found in chronic pain
8. A site for sore eyes: New target for allergies found under the eyelid
9. Chemicals found in cherries may help fight diabetes
10. Thanks for the memories: cinematic portrayal of amnesia is profoundly misleading
11. Very high prevalence of virus linked to cervical cancer found in adolescent women

Post Your Comments:
(Date:8/29/2014)... York, (PRWEB) August 29, 2014 ALS, more ... condition that damages the motor neurons in the brain and ... of the nerve cells controlling movement are harmed, which causes ... Eventually this leads to death. , ALS is a disease ... and as many as 30,000 Americans have the disease at ...
(Date:8/29/2014)... 29, 2014 And the results are in! ... & Caicos Islands, is voted a favorite with tourists and ... in the World in the Travelers' Choice Awards on the ... from all across the globe pick their favorites, and the ... in multiple categories. , The Venetian on Grace ...
(Date:8/29/2014)... Reston, VA (PRWEB) August 29, 2014 ... (HHS), Food and Drug Administration (FDA), Center for ... five-year, single-award, indefinite delivery, indefinite quantity (IDIQ) contract ... Operations and Maintenance” and “Development, Modernization and Enhancement ... VersaTech and CRGT. , Overarching contract objectives ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 The Winscribe ... Allen to Chief Executive Officer effective from 1st September ... Officer for Winscribe. , “During this time of growth, ... Greg Allen,” said Matthew Weavers, Winscribe’s Founder and Chairman ... a wealth of commercial, IT and management experience gained ...
(Date:8/28/2014)... Sarasota, FL (PRWEB) August 29, 2014 ... company that brings pharmaceutical industry precision to the ... granted zoning approval for its primary location in ... quickly and decisively with a total commitment to ... look forward to creating," says David Wright, President ...
Breaking Medicine News(10 mins):Health News:Charity Event to Raise Awareness and Donations for the ALS Foundation 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 3Health News:Winscribe Names Greg Allen as CEO 2Health News:Sarasota County Approves Zoning for Leading Medical Cannabis Firm AltMed 2
(Date:8/28/2014)... 28, 2014   Edison Nation Medical , ... worldwide search for product ideas to improve the ... ideas uncovered through the 6-month search ( www.EdisonNationMedical.com/Seniors ... manufacturers and healthcare retailers with whom Edison Nation ... individuals age 65 and older. The ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of the ... complications from the flu, pneumonia, shingles and other ... have declared September to be Senior Vaccination Month. ... it is important that adults ages 65 years ... vaccinations. CVS pharmacists and MinuteClinic nurse practitioners and ...
(Date:8/28/2014)... , Aug. 28, 2014  Stryker Orthopaedics, the Official Joint ... bringing its message of joint health to golf fans at ... at the Deutsche Bank Championship. The company,s fan destination – ... Fan Zone on 9" at the TPC Boston in ... th .    At the Deutsche Bank Championship, ...
Breaking Medicine Technology:Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
Cached News: